EdgarLookup

Citius Pharmaceuticals, Inc. — All Filings

617 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-KT 10-Q 25-NSE 3 3/A 4 4/A 424B3 424B4 424B5 425 8-A12B 8-A12G 8-K 8-K/A ARS CERTNAS CORRESP CT ORDER D D/A DEF 14A DEFA14A EFFECT FWP NT 10-K NT 10-Q POS AM PRE 14A PRER14A S-1 S-1/A S-3 S-3/A S-3MEF S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
8-K CURRENT REPORT 0001213900-24-113158 Dec 27, 2024
10-K ANNUAL REPORT 0001213900-24-113149 Dec 27, 2024 Sep 30, 2024
8-K FORM 8-K 0001213900-24-111212 Dec 20, 2024 Dec 18, 2024
SC 13D/A AMENDMENT NO. 2 TO SCHEDULE 13D 0001213900-24-103453 Nov 27, 2024
8-K CURRENT REPORT 0001213900-24-102833 Nov 26, 2024 Nov 25, 2024
8-K CURRENT REPORT 0001213900-24-102265 Nov 25, 2024
424B5 PROSPECTUS SUPPLEMENT 0001213900-24-099369 Nov 18, 2024
8-K CURRENT REPORT 0001213900-24-099649 Nov 18, 2024 Nov 15, 2024
8-K CURRENT REPORT 0001213900-24-097495 Nov 13, 2024 Nov 6, 2024
4 0001213900-24-096889 Nov 12, 2024 Nov 7, 2024
4 0001213900-24-096890 Nov 12, 2024 Nov 7, 2024
4 0001213900-24-096891 Nov 12, 2024 Nov 7, 2024
4 0001213900-24-096892 Nov 12, 2024 Nov 7, 2024
4 0001213900-24-096893 Nov 12, 2024 Nov 7, 2024
4 0001213900-24-096894 Nov 12, 2024 Nov 7, 2024
4 0001213900-24-096888 Nov 12, 2024 Nov 7, 2024
4 0001213900-24-096895 Nov 12, 2024 Nov 7, 2024
4 0001213900-24-096887 Nov 12, 2024 Nov 7, 2024
8-K CURRENT REPORT 0001213900-24-096268 Nov 12, 2024 Nov 11, 2024
4 0001213900-24-082813 Sep 27, 2024 Aug 14, 2024
8-K FORM 8-K 0001213900-24-082809 Sep 27, 2024 Sep 25, 2024
4 0001213900-24-082812 Sep 27, 2024 Aug 14, 2024
8-K CURRENT REPORT 0001213900-24-078288 Sep 13, 2024 Sep 9, 2024
8-K FORM 8-K 0001213900-24-077777 Sep 11, 2024 Sep 10, 2024
8-K CURRENT REPORT 0001213900-24-076108 Sep 5, 2024
4 OWNERSHIP DOCUMENT 0001213900-24-074505 Aug 30, 2024 Mar 4, 2024
4 OWNERSHIP DOCUMENT 0001213900-24-074506 Aug 30, 2024 Mar 13, 2024
SC 13D SCHEDULE 13D 0001213900-24-070284 Aug 16, 2024
8-K CURRENT REPORT 0001213900-24-070285 Aug 16, 2024 Aug 12, 2024
3 0001213900-24-069234 Aug 14, 2024 Aug 12, 2024
4 0001213900-24-069245 Aug 14, 2024 Aug 12, 2024
8-K CURRENT REPORT 0001213900-24-067778 Aug 12, 2024
10-Q QUARTERLY REPORT 0001213900-24-067732 Aug 12, 2024 Jun 30, 2024
424B5 PROSPECTUS SUPPLEMENT 0001213900-24-067764 Aug 12, 2024
8-K CURRENT REPORT 0001213900-24-066357 Aug 8, 2024
8-K CURRENT REPORT 0001213900-24-045573 May 21, 2024
10-Q QUARTERLY REPORT 0001213900-24-042920 May 14, 2024 Mar 31, 2024
8-K CURRENT REPORT 0001213900-24-042966 May 14, 2024
SC 13G/A 0001086364-24-007620 May 8, 2024
8-K CURRENT REPORT 0001213900-24-037861 Apr 30, 2024 Apr 25, 2024
424B5 PROSPECTUS SUPPLEMENT 0001213900-24-036696 Apr 26, 2024
8-K CURRENT REPORT 0001213900-24-030829 Apr 5, 2024 Apr 3, 2024
4 0001213900-24-030812 Apr 5, 2024 Apr 3, 2024
4 0001213900-24-030811 Apr 5, 2024 Apr 3, 2024
3 0001213900-24-023481 Mar 18, 2024 Mar 12, 2024
8-K FORM 8-K 0001213900-24-023483 Mar 18, 2024
4 0001213900-24-023487 Mar 18, 2024 Mar 14, 2024
8-K CURRENT REPORT 0001213900-24-022184 Mar 13, 2024 Mar 12, 2024
EFFECT 9999999995-24-000586 Mar 1, 2024
CORRESP 0001213900-24-018483 Feb 29, 2024